Nipro (FRA:5FA) Owner Earnings per Share (TTM): -0.04 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:5FA Nipro Corp FRA:5FA
78 GF Score
Price €7.90
GF Value €8.14
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Nipro Owner Earnings per Share (TTM)?

Nipro FRA:5FA 78 Owner Earnings per Share (TTM) is -0.04 as of Mar. 2026. GuruFocus rates FRA:5FA with a GF Score™ of 78/100 and a GF Value™ of €8.14 (Fairly Valued). The stock has 6 warning signs investors should review. Among 319 Medical Devices & Instruments companies, Nipro ranks worse than 313479.31% on this metric.

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Nipro does not have enough data to calculate Owner Earnings per Share (TTM), so as Price-to-Owner-Earnings ratio.


The historical rank and industry rank for Nipro's Owner Earnings per Share (TTM) or its related term are showing as below:


During the past 13 years, the highest Price-to-Owner-Earnings ratio of Nipro was 6.65. The lowest was 6.33. And the median was 6.53.


FRA:5FA's Price-to-Owner-Earnings is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 25.74
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

Nipro's Earnings per Share (Diluted) for the three months ended in Mar. 2026 was €-0.09. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was €0.42. It's PE Ratio (TTM) ratio for today is 18.68.

Nipro's EPS without NRI for the three months ended in Mar. 2026 was €-0.06. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was €0.34. It's PE Ratio without NRI ratio for today is 23.44.


Be Aware

Assumption: Companies usually do not report maintenance capital expenditures and growth capital expenditures separately. Here we use estimated numbers and average them over 5 years. The method to estimate maintenance capital expenditures can be found in above part 4.

Note: GuruFocus' Change In Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And it includes non-current parts of assets and liabilities.


Nipro Owner Earnings per Share (TTM) Related Terms


Nipro Owner Earnings per Share (TTM) Historical Data

* Premium members only.

The historical data trend for Nipro's Owner Earnings per Share (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nipro Owner Earnings per Share (TTM) Chart

Nipro Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Owner Earnings per Share (TTM)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 1.20 -0.04

Nipro Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Owner Earnings per Share (TTM) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -0.04 0.00

FRA:5FA vs ISRG, BDX, RMD: Owner Earnings per Share (TTM) Comparison

For the Medical Instruments & Supplies subindustry, Nipro's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nipro Price-to-Owner-Earnings vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nipro's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Nipro's Price-to-Owner-Earnings falls into.


FRA:5FA
78GF Score
Nipro Corp FRA:5FA
Owner Earnings per Share (TTM) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nipro Owner Earnings per Share (TTM) Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

To make it simple, then you will have:

Owner Earnings per Share (TTM) = (Net Income + Depreciation, Depletion and Amortization + Change In Deferred Tax - 5Y Average of Maintenance Capital Expenditure + Change In Working Capital) / Shares Outstanding (Diluted Average)

Nipro does not have enough data to calculate Owner Earnings per Share (TTM). Please check Wal-Mart Stores Inc, as your reference.

What does a Owner Earnings per Share (TTM) of -0.04 mean?
Nipro (FRA:5FA) has a Owner Earnings per Share (TTM) of -0.04 as of Mar. 2026. Warren Buffett defined owner earnings as reported earnings plus depreciation less average maintenance capital expenditure. View historical data on Nipro. According to the industry distribution chart, Nipro ranks #999999 out of 319 companies in the Medical Devices & Instruments industry.
Is Nipro's Owner Earnings per Share (TTM) too high?
Nipro's current Owner Earnings per Share (TTM) is -0.04. Based on the distribution chart, Nipro ranks #999999 out of 319 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Nipro has a GF Score™ of 78/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Nipro's Owner Earnings per Share (TTM) compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Nipro ranks #999999 out of 319 companies for Owner Earnings per Share (TTM). This places Nipro in the lower half of its industry. The industry median Owner Earnings per Share (TTM) is 25.74. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Owner Earnings per Share (TTM) for a Medical Devices & Instruments company?
The median Owner Earnings per Share (TTM) among Medical Devices & Instruments companies is 25.74, based on 319 companies in the industry. Companies in the top quartile (top 25%) have a Owner Earnings per Share (TTM) significantly above this median, while those in the bottom quartile fall well below. However, Owner Earnings per Share (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Owner Earnings per Share (TTM) mean?
A high Owner Earnings per Share (TTM) can signal that a stock is expensive relative to its fundamentals. Warren Buffett defined owner earnings as reported earnings plus depreciation less average maintenance capital expenditure. View historical data on Nipro. For the Medical Devices & Instruments industry, the median Owner Earnings per Share (TTM) is 25.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nipro's current Owner Earnings per Share (TTM) is -0.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nipro stock overvalued right now?
Based on GuruFocus' analysis, Nipro (FRA:5FA) is currently considered Fairly Valued. The stock's GF Value™ is €8.14, compared to a current price of €7.90 — trading 2.9% below its estimated fair value. The current Owner Earnings per Share (TTM) is -0.04. Nipro's overall GF Score™ is 78/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Owner Earnings per Share (TTM) calculated?
Owner Earnings per Share (TTM) is calculated from a company's financial statements. For Nipro (FRA:5FA), the current Owner Earnings per Share (TTM) is -0.04 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nipro (FRA:5FA) Overvalued in 2026?

Based on GuruFocus' analysis, Nipro stock appears to be undervalued. The current stock price of €7.90 is trading 2.9% below its estimated GF Value™ of €8.14. GuruFocus considers Nipro to be Fairly Valued.

Key valuation signals for FRA:5FA:

  • Owner Earnings per Share (TTM): -0.04
  • GF Value™: €8.14 vs. price of €7.90 (2.9% below fair value)
  • GF Score™: 78/100 with 6 warning signs

No single metric tells the full story. See the FRA:5FA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nipro Business Description

Other Exchanges 8086:Japan
Address 3-9-3 Honjo-Nishi Kita-ku, Osaka, JPN, 531-8510
Nipro Corp develops medical devices, most of which are related to dialysis and artificial organs. The firm operates in four segments: medical, pharmaceutical, glass, and other. The medical segment contributes the majority of revenue. It sells products related to injections, infusions, artificial organs, and cell cultures, as well as medical equipment for renal treatment, diabetes, and generic drugs. Renal products contribute the largest proportion of sales within the medical segment. The pharmaceutical segment manufactures pharmaceuticals, including oral drugs and injectables, which are supplied to pharmaceutical companies in Japan. The glass business sells glass products used for medical applications, such as vials and syringes. Nipro generates the majority of its revenue in Japan.
78GF Score

Get the complete analysis for FRA:5FA

Owner Earnings per Share (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€7.90
Price
€8.14
GF Value